BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 18630736)

  • 1. Plasma-derived microparticles for biomarker discovery.
    Smalley DM; Ley K
    Clin Lab; 2008; 54(3-4):67-79. PubMed ID: 18630736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
    Lee HJ; Lee EY; Kwon MS; Paik YK
    Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in selected reaction monitoring MS-driven plasma protein biomarker analysis.
    Chiu CL; Randall S; Molloy MP
    Bioanalysis; 2009 Jul; 1(4):847-55. PubMed ID: 21083142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker discovery from body fluids using mass spectrometry.
    Villar-Garea A; Griese M; Imhof A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):105-14. PubMed ID: 17097359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of abundant protein depletion and multi-lectin affinity chromatography (M-LAC) for plasma protein biomarker discovery.
    Plavina T; Wakshull E; Hancock WS; Hincapie M
    J Proteome Res; 2007 Feb; 6(2):662-71. PubMed ID: 17269723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.
    Ray S; Reddy PJ; Jain R; Gollapalli K; Moiyadi A; Srivastava S
    Proteomics; 2011 Jun; 11(11):2139-61. PubMed ID: 21548090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to dimensionality reduction in proteomic biomarker studies.
    Hilario M; Kalousis A
    Brief Bioinform; 2008 Mar; 9(2):102-18. PubMed ID: 18310106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in proximal fluid proteomics for disease biomarker discovery.
    Teng PN; Bateman NW; Hood BL; Conrads TP
    J Proteome Res; 2010 Dec; 9(12):6091-100. PubMed ID: 21028795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein biomarker discovery and validation: the long and uncertain path to clinical utility.
    Rifai N; Gillette MA; Carr SA
    Nat Biotechnol; 2006 Aug; 24(8):971-83. PubMed ID: 16900146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical proteomics: the promises and challenges of mass spectrometry-based biomarker discovery.
    deVera IE; Katz JE; Agus DB
    Clin Adv Hematol Oncol; 2006 Jul; 4(7):541-9. PubMed ID: 17147241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the development of plasma protein biomarkers.
    Surinova S; Schiess R; Hüttenhain R; Cerciello F; Wollscheid B; Aebersold R
    J Proteome Res; 2011 Jan; 10(1):5-16. PubMed ID: 21142170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
    Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F
    Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry.
    Ahmed FE
    J Sep Sci; 2009 Mar; 32(5-6):771-98. PubMed ID: 19219839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming the dynamic range problem in mass spectrometry-based shotgun proteomics.
    Wu L; Han DK
    Expert Rev Proteomics; 2006 Dec; 3(6):611-9. PubMed ID: 17181475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry-based biomarker discovery.
    Zhou W; Petricoin EF; Longo C
    Methods Mol Biol; 2012; 823():251-64. PubMed ID: 22081350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma proteomics: a noninvasive window on pathology and pediatric cardiac surgery.
    Lull ME; Freeman WM; Myers JL; Midgley F; Kimatian SJ; Undar A; Vrana KE
    ASAIO J; 2006; 52(5):562-6. PubMed ID: 16966860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proof-of-principle gel-free proteomics strategy for the identification of predictive biomarkers for the onset of pre-eclampsia.
    Blankley RT; Gaskell SJ; Whetton AD; Dive C; Baker PN; Myers JE
    BJOG; 2009 Oct; 116(11):1473-80. PubMed ID: 19663911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of urinary proteomics/peptidomics.
    Albalat A; Mischak H; Mullen W
    Expert Rev Proteomics; 2011 Oct; 8(5):615-29. PubMed ID: 21999832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-performance proteomics as a tool in biomarker discovery.
    Meyer HE; Stühler K
    Proteomics; 2007 Sep; 7 Suppl 1():18-26. PubMed ID: 17893859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry-coupled techniques for viral-related disease biomarker identification.
    Rhea JM; Diwan CA; Molinaro RJ
    Biomark Med; 2010 Dec; 4(6):859-70. PubMed ID: 21133707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.